Abstract:Background: Non-coding RNAs (ncRNAs), like long ncRNAs (lncRNAs) and microRNAs (miRNAs), are confirmed to play important roles in the tumorigenesis and deterioration of non-small cell lung cancer (NSCLC). However, the underlying expression profiling and prospective signal pathways of miRNAs associated with lncRNA HOXA11 antisense RNA (HOXA11-AS) in NSCLC remain unknown. Methods: HOXA11-AS was knocked down in A549 cell line and a microarray assay was used to detect the changes of the miRNA profiles. Four miRNA target prediction algorithms were applied to predict the potential target genes of the differentially expressed miRNAs. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interactions (PPIs) and network analysis, were performed to investigate the potential functions, pathways and networks of the target genes. The different expression of HOXA11-AS between normal lung and NSCLC tissues was further verified by the data in The Cancer Genome Atlas (TCGA). Additionally, the relationship between the expression of HOXA11-AS and clinical diagnostic value was analyzed by receiver operating characteristic (ROC) curve. Results: Among all the miRNAs from the microarray, 43 and 18 miRNAs were upregulated and downregulated in NSCLC, respectively. According to the degree of the fold change, p value and false discovery rate (FDR), the top five upregulated and downregulated miRNAs were selected for further investigation. GO analysis on the target genes revealed that these de-regulated miRNAs were involved in complex cellular pathways, such as transcription, cell junction and transcription factor activity. KEGG pathway analysis showed that Wnt signaling pathway might be involved in regulating these 10 candidate miRNAs. XRN1 (degree = 23) and EP300 (degree = 20) had highest degree and interactions in the PPI network. Additionally, we found that HOXA11-AS was upregulated in lung adenocarcinoma and squamous cell carcinoma tissues based on TCGA database. The ROC curve revealed that the area under curve (AUC) of HOXA11-AS was 0.727 (95% CI 0.663~0.790) for lung adenocarcinoma and 0.933 (95% CI 0.906~0.960) for squamous cell carcinoma patients. Conclusions: Our results provide significant information on miRNAs related to HOXA11-AS in NSCLC and we hypothesize that HOXA11-AS might play a key role in NSCLC by regulating the expression of miRNAs through Wnt signaling pathway, which would be valuable for further investigation into the possible molecular mechanisms in NSCLC.

HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer

Lncrna Hoxa11-As Promotes Proliferation And Invasion Of Gastric Cancer By Scaffolding The Chromatin Modification Factors Prc2, Lsd1, And Dnmt1

HOXA11-AS: a Novel Regulator in Human Cancer Proliferation and Metastasis

Data from LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1

Clinical Significance and Effect of Lncrna HOXA11-AS in NSCLC: A Study Based on Bioinformatics, in Vitro and in Vivo Verification

The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer

HOXA11-AS regulates JAK-STAT pathway by miR-15a-3p/STAT3 axis to promote the growth and metastasis in liver cancer

Prospective target gene network of key miRNAs influenced by long non-coding RNA HOXA 11-AS in NSCLC cells

HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway

Supplementary Figure S1 from LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1

CTCF-induced Upregulation of HOXA11-AS Facilitates Cell Proliferation and Migration by Targeting Mir-518B/actn4 Axis in Prostate Cancer

The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.

Targeting HOXA11‐AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo

Supplementary Table S2 from LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1

Supplementary Figure S5 from LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1

Downregulation of Lncrna-Hoxa11-as Modulates Proliferation and Stemness in Glioma Cells

Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression

+HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10

Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches

The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.